Prompt response of refractory Schnitzler syndrome to treatment with anakinra

Journal of the American Academy of Dermatology

Volumn 56, Issue 5 SUPPL., 2007, Pages

  Schneider, Stefan W ^a   Gaubitz, Markus ^b   Luger, Thomas A ^a   Bonsmann, Gisela ^a  

^a Departments of Dermatology   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLEMASTINE; COLCHICINE; DAPSONE; ETORICOXIB; FEXOFENADINE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN M; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; LEVOCETIRIZINE; METHOTREXATE; PENTOXIFYLLINE; PREDNISOLONE; PROMETHAZINE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; ROFECOXIB;

ADULT; ANEMIA; ARTICLE; BONE PAIN; BONE SCINTISCANNING; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; HEADACHE; HUMAN; INFECTION; INJECTION SITE REACTION; LABORATORY TEST; LYMPHOPROLIFERATIVE DISEASE; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; PATHOGENESIS; PRIORITY JOURNAL; SCHNITZLER SYNDROME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; URTICARIA;

HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MIDDLE AGED; SCHNITZLER SYNDROME; TIME FACTORS; TREATMENT OUTCOME;

EID: 34047260576     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.05.057     Document Type: Article

References (13)

1. Schnitzler L., Hurez D., and Verret J.L. Chronic urticaria-osteo-condensation-macroglobulinemia. Principal case. Study of 20 cases. Ann Dermatol Venereol 116 (1989) 547-550
2. de Koning H.D., Bodar E.J., Simon A., van der Hilst J.C., Netea M.G., and van der Meer J.W. Beneficial response to anakinra and thalidomide in Schnitzler's syndrome. Ann Rheum Dis 65 (2006) 542-544
3. Lipsker D., Veran Y., Grunenberger F., Cribier B., Heid E., and Grosshans E. The Schnitzler syndrome. Four new cases and review of the literature. Medicine (Baltimore) 80 (2001) 37-44
4. Nashan D., Sunderkotter C., Bonsmann G., Luger T., and Goerdt S. Chronic urticaria, arthralgia, raised erythrocyte sedimentation rate and IgG paraproteinaemia: a variant of Schnitzler's syndrome?. Br J Dermatol 133 (1995) 132-134
5. Lipsker D., Imrie K., Simon A., and Sullivan K.E. Hot and hobbling with hives: Schnitzler syndrome. Clin Immunol 119 (2006) 131-134
6. Almerigogna F., Giudizi M.G., Cappelli F., and Romagnani S. Schnitzler's syndrome: what's new?. J Eur Acad Dermatol Venereol 16 (2002) 214-219
7. Lebbe C., Rybojad M., Klein F., Oksenhendler E., Catala M., Danon F., et al. Schnitzler's syndrome associated with sensorimotor neuropathy. J Am Acad Dermatol 30 (1994) 316-318
8. Lipsker D., Spehner D., Drillien R., Schmitt P., Cribier B., Heid E., et al. Schnitzler syndrome: heterogeneous immunopathological findings involving IgM-skin interactions. Br J Dermatol 142 (2000) 954-959
9. Saurat J.H., Schifferli J., Steiger G., Dayer J.M., and Didierjean L. Anti-interleukin-1 alpha autoantibodies in humans: characterization, isotype distribution, and receptor-binding inhibition-higher frequency in Schnitzler's syndrome (urticaria and macroglobulinemia). J Allergy Clin Immunol 88 (1991) 244-256
10. Arend W.P., Malyak M., Guthridge C.J., and Gabay C. Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 16 (1998) 27-55
11. Fleischmann R.M., Schechtman J., Bennett R., Handel M.L., Burmester G.R., Tesser J., et al. Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: a large, international, multicenter, placebo-controlled trial. Arthritis Rheum 48 (2003) 927-934
12. Hoffman H.M., and Patel D.D. Genomic-based therapy: targeting interleukin-1 for autoinflammatory diseases. Arthritis Rheum 50 (2004) 345-349
13. Martinez-Taboada V.M., Fontalba A., Blanco R., and Fernandez-Luna J.L. Successful treatment of refractory Schnitzler syndrome with anakinra: comment on the article by Hawkins et al. Arthritis Rheum 52 (2005) 2226-2227